Previous 10 | Next 10 |
Harrow Health’s (HROW) Q1 2022 Earnings Conference Call May 05, 2022 04:45 PM ET Company Participants Jamie Webb - Director of Communications and Investor Relations Mark Baum - Chief Executive Officer and Chairman of the Board Andrew Boll - Chief Financial Officer Conference Call Parti...
The following slide deck was published by Harrow Health, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Harrow Health, Inc. 2022 Q1 - Results - Earnings Call Presentation
Harrow Health press release (NASDAQ:HROW): Q1 Non-GAAP EPS of $0.03 beats by $0.07. Revenue of $22.12M (+43.3% Y/Y) beats by $2.64M. For further details see: Harrow Health Non-GAAP EPS of $0.03 beats by $0.07, revenue of $22.12M beats by $2.64M
Seventh Consecutive Quarter of Record Results Highlights for First Quarter 2022: Record revenues of $22.1 million, up 43% over $15.4 million for the prior-year quarter Record gross profit of $16.2 million, up 38% over $11.7 million for the prior-year quarter Record...
Bioavailability of MELT-210 Compares Favorably to Reference Drug Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel approaches for procedural sedation and analgesia, today announced top-line results of its phase 1 pharmacokinetics (PK) study...
Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic‑focused healthcare company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the B. Riley Securities’ Annual Neuro & Ophthalmology Investor Confer...
Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the first quarter ended March 31, 2022, on Thursday, May 5, 2022, after the market close. The Company will also post its first quarter Letter to S...
Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, today announced the appointments of Perry J. Sternberg and Marty Makary, M.D., M.P.H. to the Company’s Board of Directors, effective immediately. The Company also announced that Robert J. Kammer has res...
The following slide deck was published by Harrow Health, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Harrow Health, Inc. 2021 Q4 - Results - Earnings Call Presentation
Harrow Health, Inc. (HROW) Q4 2021 Earnings Conference Call March 10, 2022 4:45 PM ET Company Participants Jamie Webb – Director-Communications and Investor Relations Mark L. Baum – Chief Executive Officer Andrew Boll – Chief Financial Officer Conference Call Participants...
News, Short Squeeze, Breakout and More Instantly...
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on August 8, 2024 Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will report its financial results for the second quarter ended June 30, 2024, on Wednesday, August...
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that its management team would attend the 2024 American Society of Retina Specialists (ASRS) Annual Meeting, taking place in Stockholm, Sweden, from July 17-20, 2024. The ASRS Annual Meeting brings tog...
Contract Enhances Purchasing Power for 340B Prime Vendor Program (PVP) Participants; Aligns with Harrow’s Mission to Make Its Products Accessible and Affordable Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that as of July 1, 2024, ...